SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ADAG

Adagene Inc. (NASDAQ:ADAG)

CN · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.44+0.03 (+1.24%)
 
Market cap
$91.9M
Insider Score
Analyst consensus
Listed since
Feb 9, 2021
Insider Score
/ 100
ADAG Insider Score

Adagene Inc. has a live Insider Score.

Scored on 5 qualifying trades from 3 insiders in the last 90 days.

Unlock the score

ADAG Income Statement

Fiscal PeriodQ2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q1 2024
Period EndingJun 30, 2026Dec 31, 2025Jun 30, 2025Dec 31, 2024Jun 30, 2024Mar 31, 2024
Revenue1.62 M7.69 M0.00103.20 K0.000.00
Revenue Growth (YoY)——-100.00 %-74.70 %-100.00 %-100.00 %
Cost of Revenue256.46 K282.32 K300.33 K926.25 K0.000.00
Gross Profit1.37 M7.41 M-300.33 K-823.04 K-509.05 K0.00
SG&A Expense4.25 M3.41 M3.68 M3.70 M1.80 M1.80 M
R&D Expense13.74 M9.76 M11.74 M20.49 M7.36 M7.36 M
Operating Expenses17.99 M13.18 M15.43 M26.89 M9.16 M9.28 M
Operating Income-16.62 M-5.77 M-15.73 M-26.79 M-9.16 M-9.16 M
Pretax Income-16.48 M-4.44 M-13.51 M-24.94 M-8.51 M-8.51 M
Tax Provision-68.16 K-299.17 K459.13-18.25 K694.00694.00
Net Income-16.41 M-4.14 M-13.51 M-24.92 M-8.51 M-8.51 M
EPS (Basic)-0.36-0.11-0.36-0.71-0.24-0.24
EPS (Diluted)-0.36-0.11-0.36-0.71-0.24-0.24
Shares Outstanding45.30 M37.91 M37.69 M36.71 M35.12 M35.12 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.